Interpretation of the Chinese guideline for diagnosis and management of drug-induced liver injury (2023 version)
10.3760/cma.j.cn501113-20230829-00077
- VernacularTitle:《中国药物性肝损伤诊治指南（2023年版）》解读
- Author:
Yimin MAO
1
Author Information
1. 上海交通大学医学院附属仁济医院 上海市消化疾病研究所 上海市脂肪性肝病诊治研究中心，上海 200001
- Keywords:
Drug-induced liver injury;
Guideline;
Interpretation
- From:
Chinese Journal of Hepatology
2024;32(4):312-317
- CountryChina
- Language:Chinese
-
Abstract:
Drug can cause almost all known types of acute, subacute, and chronic liver injuries. Drug-induced liver injury (DILI) is an important cause of unexplained liver injury in clinical practice. Correct diagnosis of DILI is challenging due to lack of specific diagnostic biomarkers, especially in patients with pre-existing liver disease and multiple concomitant drugs. A comprehensive understanding of the risk factors, clinical features, and prognosis of liver injury caused by different drugs will help physicians to recognize, diagnose, and manage it timely. Although the guideline was developed based on evidence-based medicine provided by the latest studies, there is limited high-quality evidence in the field of DILI. Therefore, this guideline should be interpreted with caution, and physicians should adopt an optimal diagnostic and therapeutic strategy for individual patients within the framework of the guideline.
